<VariationArchive RecordType="classified" VariationID="930182" VariationName="NM_001922.5(DCT):c.1307_1320del (p.Phe435_Phe436insTer)" VariationType="Deletion" Accession="VCV000930182" Version="4" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2022-04-25" DateCreated="2020-12-17" MostRecentSubmission="2021-04-23">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="918502" VariationID="930182">
      <GeneList>
        <Gene Symbol="DCT" FullName="dopachrome tautomerase" GeneID="1638" HGNC_ID="HGNC:2709" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>13q32.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="13" Accession="NC_000013.11" start="94436811" stop="94549406" display_start="94436811" display_stop="94549406" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="13" Accession="NC_000013.10" start="95091834" stop="95131935" display_start="95091834" display_stop="95131935" Strand="-" />
          </Location>
          <OMIM>191275</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_001922.5(DCT):c.1307_1320del (p.Phe435_Phe436insTer)</Name>
      <CanonicalSPDI>NC_000013.11:94443496:AGTCACTGGAGGGAAG:AG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>13q32.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="13" Accession="NC_000013.11" start="94443497" stop="94443510" display_start="94443497" display_stop="94443510" variantLength="14" positionVCF="94443496" referenceAlleleVCF="TAGTCACTGGAGGGA" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="13" Accession="NC_000013.10" start="95095751" stop="95095764" display_start="95095751" display_stop="95095764" variantLength="14" positionVCF="95095750" referenceAlleleVCF="TAGTCACTGGAGGGA" alternateAlleleVCF="T" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000013.10" sequenceAccession="NC_000013" sequenceVersion="10" change="g.95095753_95095766del" Assembly="GRCh37">
            <Expression>NC_000013.10:g.95095753_95095766del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000013.11" sequenceAccession="NC_000013" sequenceVersion="11" change="g.94443499_94443512del" Assembly="GRCh38">
            <Expression>NC_000013.11:g.94443499_94443512del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001129889.3" sequenceAccession="NM_001129889" sequenceVersion="3" change="c.1406_1419del">
            <Expression>NM_001129889.3:c.1406_1419del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001123361.1" sequenceAccession="NP_001123361" sequenceVersion="1" change="p.Phe468_Phe469insTer">
            <Expression>NP_001123361.1:p.Phe468_Phe469insTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001322182.2" sequenceAccession="NM_001322182" sequenceVersion="2" change="c.374_387del">
            <Expression>NM_001322182.2:c.374_387del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001309111.1" sequenceAccession="NP_001309111" sequenceVersion="1" change="p.Phe124_Phe125insTer">
            <Expression>NP_001309111.1:p.Phe124_Phe125insTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001322183.2" sequenceAccession="NM_001322183" sequenceVersion="2" change="c.374_387del">
            <Expression>NM_001322183.2:c.374_387del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001309112.1" sequenceAccession="NP_001309112" sequenceVersion="1" change="p.Phe124_Phe125insTer">
            <Expression>NP_001309112.1:p.Phe124_Phe125insTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001322184.2" sequenceAccession="NM_001322184" sequenceVersion="2" change="c.374_387del">
            <Expression>NM_001322184.2:c.374_387del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001309113.1" sequenceAccession="NP_001309113" sequenceVersion="1" change="p.Phe124_Phe125insTer">
            <Expression>NP_001309113.1:p.Phe124_Phe125insTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001322185.2" sequenceAccession="NM_001322185" sequenceVersion="2" change="c.374_387del">
            <Expression>NM_001322185.2:c.374_387del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001309114.1" sequenceAccession="NP_001309114" sequenceVersion="1" change="p.Phe124_Phe125insTer">
            <Expression>NP_001309114.1:p.Phe124_Phe125insTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001322186.2" sequenceAccession="NM_001322186" sequenceVersion="2" change="c.1118_1131del">
            <Expression>NM_001322186.2:c.1118_1131del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001309115.1" sequenceAccession="NP_001309115" sequenceVersion="1" change="p.Phe372_Phe373insTer">
            <Expression>NP_001309115.1:p.Phe372_Phe373insTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001922.5" sequenceAccession="NM_001922" sequenceVersion="5" change="c.1307_1320del" MANESelect="true">
            <Expression>NM_001922.5:c.1307_1320del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001913.2" sequenceAccession="NP_001913" sequenceVersion="2" change="p.Phe435_Phe436insTer">
            <Expression>NP_001913.2:p.Phe435_Phe436insTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="191275.0002" DB="OMIM" />
        <XRef Type="rs" ID="1882493359" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001922.5(DCT):c.1307_1320del (p.Phe435_Phe436insTer) AND Albinism" Accession="RCV001270367" Version="1">
        <ClassifiedConditionList TraitSetID="8642">
          <ClassifiedCondition DB="MedGen" ID="C0001916">Albinism</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2020-06-15" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001922.5(DCT):c.1307_1320del (p.Phe435_Phe436insTer) AND Oculocutaneous albinism type 8" Accession="RCV001290118" Version="3">
        <ClassifiedConditionList TraitSetID="65222">
          <ClassifiedCondition DB="MedGen" ID="C5436929">Oculocutaneous albinism type 8</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2021-04-20" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2021-04-20" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2020-12-17" MostRecentSubmission="2021-04-23">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">33100333</ID>
        </Citation>
        <DescriptionHistory Dated="2021-01-30">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="65222" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="55750" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">OCULOCUTANEOUS ALBINISM, TYPE VIII</ElementValue>
                <XRef Type="MIM" ID="619165" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Oculocutaneous albinism type 8</ElementValue>
                <XRef ID="MONDO:0030899" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">OCA8</ElementValue>
                <XRef Type="MIM" ID="619165" DB="OMIM" />
              </Symbol>
              <XRef ID="597733" DB="Orphanet" />
              <XRef ID="C5436929" DB="MedGen" />
              <XRef ID="MONDO:0030899" DB="MONDO" />
              <XRef Type="MIM" ID="619165" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="8642" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="13245" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Albinism</ElementValue>
                <XRef ID="Albinism/294" DB="Genetic Alliance" />
                <XRef ID="HP:0001022" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0043209" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5768" />
                <XRef ID="5768" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="C0001916" DB="MedGen" />
              <XRef ID="MONDO:0043209" DB="MONDO" />
              <XRef Type="primary" ID="HP:0001022" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2694169" SubmissionDate="2020-06-29" DateLastUpdated="2020-12-17" DateCreated="2020-12-17">
        <ClinVarSubmissionID localKey="SUB7603850" submittedAssembly="GRCh37" title="SUB7603850" />
        <ClinVarAccession Accession="SCV001337676" DateUpdated="2020-12-17" DateCreated="2020-12-17" Type="SCV" Version="1" SubmitterName="Laboratoire de Genetique Moleculaire, Centre Hospitalier Universitaire de Bordeaux" OrgID="506590" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-06-15">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>We sequenced a panel of genes with known or predicted involvement in melanogenesis in 230 unsolved albinism patients in order to search for new mutations. In two unrelated patients we identified variants in the Dopachrome tautomerase (DCT) (also called Tyrosinase-related protein 2, TYRP2) gene. One patient was compound heterozygous for a 14 bp deletion in exon 9 and a c.118T&gt;A p.(Cys40Ser) variant. The second patient was homozygous for a c.183C&gt;G p.(Cys61Trp) variant. Both patients had mild hair and skin hypopigmentation, and classical ocular features including nystagmus, iris and retinal hypopigmentation. We have used CRISPR/Cas9 in C57BL/6J mice to create mutations identical to the missense mutations carried by these two patients, along with one loss-of-function indel mutation. When bred to homozygosity these novel mouse mutations revealed different degrees of hypopigmentation of the coat, milder for Cys40Ser compared to Cys61Trp or the frameshift mutation. Histological analysis of the retina identified significant hypopigmentation of the retinal pigmented epithelium (RPE) indicating that a defect in RPE melanogenesis could be associated with eye and vision defects in DCT patients.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Ethnicity>Caucasian</Ethnicity>
              <GeographicOrigin>France</GeographicOrigin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">10</Age>
              <Age Type="maximum" age_unit="years">19</Age>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>female</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="CompoundHeterozygote" integerValue="1" />
            </ObservedData>
            <Comment>Patient 1 was compound heterozygous for a 14 bp deletion in exon 9 and a c.118T&gt;A p.(Cys40Ser) variant.</Comment>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="DCT">
              <Name>dopachrome tautomerase</Name>
            </Gene>
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000013.10:g.95095751_95095764del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="HP" ID="HP:0001022" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB7603850</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2913861" SubmissionDate="2021-04-20" DateLastUpdated="2021-04-23" DateCreated="2021-01-30">
        <ClinVarSubmissionID localKey="191275.0002_ALBINISM, OCULOCUTANEOUS, TYPE VIII" title="DCT, 14-BP DEL, NT1406_ALBINISM, OCULOCUTANEOUS, TYPE VIII" />
        <ClinVarAccession Accession="SCV001478266" DateUpdated="2021-04-23" DateCreated="2021-01-30" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-04-20">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">For discussion of the 14-bp deletion (c.1406_1419del, NM_001129889.2) in exon 9 of the DCT gene, causing a frameshift predicted to result in a premature termination codon (Phe469Ter), that was found in compound heterozygous state in a 12-year-old French girl with mild oculocutaneous albinism (OCA8; 619165) by Pennamen et al. (2021), see 191275.0001.</Attribute>
              <Citation>
                <ID Source="PubMed">33100333</ID>
              </Citation>
              <XRef DB="OMIM" ID="619165" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="DCT" />
          </GeneList>
          <Name>DCT, 14-BP DEL, NT1406</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">14-BP DEL, NT1406</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="191275.0002" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">ALBINISM, OCULOCUTANEOUS, TYPE VIII</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2694169" TraitType="Disease" MappingType="XRef" MappingValue="HP:0001022" MappingRef="HP">
        <MedGen CUI="C0001916" Name="Albinism" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2913861" TraitType="Disease" MappingType="Name" MappingValue="ALBINISM, OCULOCUTANEOUS, TYPE VIII" MappingRef="Preferred">
        <MedGen CUI="C5436929" Name="Oculocutaneous albinism type 8" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

